CMA announced yesterday that 10 new ingredients have been assessed by the TGA as suitable for use in listed medicines. The relevant Listing Notice permitting their use is now registered on the Federal Register of Legislative Instruments (see www.comlaw.gov.au/Details/F2015L01421).
It is anticipated that the publication of the relevant compositional guidelines, along with the necessary updates to eBS, will be finalised by the TGA COB Tuesday 15 September.
2. Calcium and Magnesium pyruvate